Advisor Group Holdings »

Plus Therapeutics shares owned by Advisor Group Holdings

Quarter-by-quarter ownership of Plus Therapeutics (PSTV) shares owned by Advisor Group Holdings from 13F filings

Historical chart of Advisor Group Holdings investment in Plus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Plus Therapeutics held by Advisor Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Plus Therapeutics by Advisor Group Holdings

Quarter filed Position value Share count Share price at filing
2024-03-31 $239 133 1.80
2023-12-31 $232 133 1.74
2023-09-30 $177 133 1.34
2023-06-30 $267 133 2.02

More positions owned by Advisor Group Holdings

Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)

View all positions for Advisor Group Holdings

Top funds holding Plus Therapeutics

Vanguard Group
Geode Capital Management
Citadel Advisors
BlackRock
Tower Research Capital
Advisor Group Holdings
Jpmorgan Chase & Co
Wells Fargo & Company
Group One Trading

View all funds holding Plus Therapeutics